BBC NEWS    BBC Sport >>   Graphics version >>   Change to World edition >>
News Front Page | World | UK | England | N Ireland | Scotland | Wales | Politics | Business | Entertainment | Science/Nature | Technology | Health | Education | Talking Point
Business Contents: Market Data | Your Money | E-Commerce | Economy | Companies | Fact Files
Tuesday, 26 November, 2002, 17:46 GMT

Glaxo backs down on CEO pay deal

GlaxoSmithKline, Europe's biggest drugs group, has bowed to shareholder pressure and held off giving a multi-million pound pay rise to its chief executive, Jean Pierre Garnier.

Big pay deals for company bosses have come under the spotlight as the government attempts to hold the line on public sector pay during the firefighters dispute.


" After taking into account shareholder views, the company has decided to postpone a decision on the matter "

GSK

GlaxoSmithKline held an emergency meeting on Tuesday, following widespread criticism of the move to increase Mr Garnier's pay package from around £6m to between £11m and £19m.

The company had said the huge increase was designed to bring the chief executive's package in line with that of his global counterparts.

But following the meeting, the company said in a statement: "After taking into account shareholder views, the company has decided to postpone a decision on the matter".

Worth the money?

Mr Garnier's proposed pay hike met with shareholder outrage, following a year in which the company itself has seen its value dwindle.

Glaxo shares have slumped by over 30% in the last 12 months, while profits fell 25% to £4.5bn in the last financial year.


" We still need to see what happens in the future "

National Association of Pension Funds

Chairman Sir Christopher Hogg reportedly visited major investors last week to gauge sentiment towards the deal.

Tuesday's announcement indicates it was not well received.

A spokeswoman for the group refused to specify terms of the new deal but said it was likely to be set "at a similar level to last year".

The National Association of Pension Funds cheered the news, and praised the company for listening to shareholders.

But it warned: "We still need to see what happens in the future".

Shareholder power

GSK's decision is the latest example of companies being forced to heed shareholder voices.

Earlier on Tuesday, the telecoms company Cable & Wireless said its chairman designate Davis Nash had resigned following shareholder pressure for a management reshuffle.

In May, insurance giant Prudential scrapped plans for a new executive bonus scheme after protests from investors.

At the CBI conference in Manchester this week, companies came under pressure to rein in big pay deals to rebuild trust with the public - damaged by the US corporate scandals.

A BBC survey showed that the public was deeply concerned about the high level of pay awards for chief executives - especially when they were not linked to results.


Related to this story:
GSK 'ready to scrap pay deal' (24 Nov 02 | Business) Investors baulk at GSK pay deal (22 Nov 02 | Business) Talks held over GSK jobs (01 Nov 02 | England) Glaxo to shed 400 jobs (26 Sep 02 | England) Aids foundation sues Glaxo (01 Jul 02 | Business) Drugs giants 'in merger talks' (31 May 02 | Business) Glaxo sheds 500 jobs (29 Nov 01 | England) The great pay divide (26 Nov 02 | Business)


Internet links: GlaxoSmithKline
The BBC is not responsible for the content of external internet sites
News Front Page | World | UK | England | N Ireland | Scotland | Wales | Politics | Business | Entertainment | Science/Nature | Technology | Health | Education | Talking Point
Business Contents: Market Data | Your Money | E-Commerce | Economy | Companies | Fact Files

^^ Back to top | BBC News Home | BBC Homepage | Feedback | ©